JP-1366 + placebo for non-erosive reflux disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 8 Sep 2025: Trial registered, NCT07160790

The trials

NCT07160790: Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease

State
Not started
Phase
Phase 3
People
321 planned
Started
2 Sep 2025
Primary completion
30 Jun 2026
Arms
Group 1: JP-1366 A mg + Placebo, Group 2: JP-1366 B mg + Placebo
Results
None posted
  1. 8 Sep 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.